Does mild persistent asthma require regular treatment?

被引：7

作者：

Fabbri, LM ^{[1
]}

机构：

[1] Univ Modena & Reggio Emilia, Policlin Modena, Clin Malattie Apparato Resp, Modena, Italy

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 15期

关键词：

D O I：

10.1056/NEJMe058020

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1589 / 1591

页数：3

共 15 条

[11]

*NHLBI WHO, 2004, GLOB IN ASTHM GLOB S

[12] Low dose inhaled budesonide and formoterol in mild persistent asthma - The OPTIMA randomized trial [J].

O'Byrne, PM ;

Barnes, PJ ;

Rodriguez-Roisin, R ;

Runnerstrom, E ;

Sandstrom, T ;

Svensson, K ;

Tattersfield, A .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (08) :1392-1397

[13] Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial [J].

Pauwels, RA ;

Pedersen, S ;

Busse, WW ;

Tan, WC ;

Chen, YZ ;

Ohlsson, SV ;

Ullman, A ;

Lamm, CJ ;

O'Byrne, PM .

LANCET, 2003, 361 (9363) :1071-1076

[14] Effects of Inhaled Corticosteroids, Leukotriene Receptor Antagonists, or Both, Plus Long-Acting β2-Agonists on Asthma Pathophysiology: A Review of the Evidence [J].

A. Maurizio Vignola .

Drugs, 2003, 63 (Suppl 2) :35-51

[15] Inhaled corticosteroid use and bone-mineral density in patients with asthma [J].

Wong, CA ;

Walsh, LJ ;

Smith, CJP ;

Wisniewski, AF ;

Lewis, SA ;

Hubbard, R ;

Cawte, S ;

Green, DJ ;

Pringle, M ;

Tattersfield, AE .

LANCET, 2000, 355 (9213) :1399-1403

← 1 2 →